1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TNFRSF21 CTRPv2 pan-cancer AAC 0.19 8e-06
mRNA GBAS CTRPv2 pan-cancer AAC 0.17 9e-06
mRNA CACTIN CTRPv2 pan-cancer AAC -0.18 9e-06
mRNA ENDOD1 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA IZUMO1R CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA FHDC1 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA HES2 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA PRRC2A CTRPv2 pan-cancer AAC -0.18 1e-05
mRNA ATP1B3 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA ADAMTS6 CTRPv2 pan-cancer AAC 0.16 1e-05
Download CSV